Statistics for Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2- carboxylate derivatives: In vitro evaluation, cell cycle analysis and QSAR studies
Total visits
views | |
---|---|
Anti-hepatocellular carcinoma activity using human HepG2 cells and hepatotoxicity of 6-substituted methyl 3-aminothieno[3,2-b]pyridine-2- carboxylate derivatives: In vitro evaluation, cell cycle analysis and QSAR studies | 578 |
Total visits per month
views | |
---|---|
December 2024 | 4 |
January 2025 | 1 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
EJMC-MJQ011_R1.pdf(legacy) | 462 |
null(legacy) | 413 |
EJMC-MJQ011_R1.pdf | 5 |
1-s2.0-S0223523411006908-main.pdf(legacy) | 2 |
22.pdf(legacy) | 1 |
Top country views
views | |
---|---|
United States | 257 |
China | 75 |
Portugal | 50 |
Russia | 29 |
Germany | 24 |
United Kingdom | 16 |
France | 15 |
Turkey | 13 |
Ukraine | 12 |
Brazil | 10 |
Sweden | 9 |
Belarus | 6 |
European Union | 6 |
Poland | 6 |
Canada | 5 |
Spain | 4 |
Netherlands | 4 |
Egypt | 3 |
Japan | 3 |
Taiwan | 3 |
Denmark | 2 |
India | 2 |
Singapore | 2 |
Italy | 1 |
South Korea | 1 |
Mongolia | 1 |
Mexico | 1 |
New Zealand | 1 |
Romania | 1 |
South Africa | 1 |